Cargando…
Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
This paper aims to analyze the ethical challenges in experimental drug use during the early stage of the COVID-19 pandemic, using Germany as a case study. In Germany uniform ethical guidelines were available early on nationwide, which was considered as desirable by other states to reduce uncertainti...
Autores principales: | Voit, Katja, Timmermann, Cristian, Steger, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197849/ https://www.ncbi.nlm.nih.gov/pubmed/34073254 http://dx.doi.org/10.3390/ijerph18115685 |
Ejemplares similares
-
Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines
por: Voit, Katja, et al.
Publicado: (2023) -
Informed Consent in Clinical Studies Involving Human Participants: Ethical Insights of Medical Researchers in Germany and Poland
por: Timmermann, Cristian, et al.
Publicado: (2022) -
Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
por: Meo, Sultan Ayoub, et al.
Publicado: (2020) -
Informed Consent in COVID-19-Research: An Ethical Analysis of Clinical Studies Performed during the Pandemic
por: Voit, Katja, et al.
Publicado: (2023) -
Access to Prenatal Testing and Ethically Informed Counselling in Germany, Poland and Russia
por: Orzechowski, Marcin, et al.
Publicado: (2021)